IL4 and asthma: The inhibition of IL-4 or its receptor in mouse paradigms of allergen-sensitized asthma has been demonstrated to reduce pulmonary swelling, blood IgE concentrations, and bronchial hyperactivity to cholinergic drugs (i.e., methacholine).